Genetics: Breast Cancer as an Exemplar

Nursing Clinics of North America

Volumn 44, Issue 3, 2009, Pages 327-338

  Hamilton, Rebekah ^a  

^a and Family Health Science   (United States)

Author keywords

Ethics; Genetics; Genomics; Nursing advocacy; Nursing competencies

Indexed keywords

ADAPTIVE BEHAVIOR; ADULT; ATTITUDE TO HEALTH; BREAST TUMOR; FAMILIAL CANCER; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; MASTECTOMY; METHODOLOGY; MUTATION; NURSE ATTITUDE; OVARIECTOMY; PATIENT REFERRAL; PEDIGREE; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT; RISK REDUCTION; TUMOR SUPPRESSOR GENE; WOMEN'S HEALTH;

ADAPTATION, PSYCHOLOGICAL; ADULT; ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MASTECTOMY; MUTATION; NEOPLASTIC SYNDROMES, HEREDITARY; NURSE'S ROLE; OVARIECTOMY; PEDIGREE; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR; WOMEN'S HEALTH;

EID: 68349148460     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2009.06.004     Document Type: Review

References (66)

1. DOE/NIH. History of the human genome project. website. Available at: (2002). http://www.ornl.gov/hgmis Accessed on January 26, 2003
2. Wooster R., and Weber B.L. Breast and ovarian cancer. N Engl J Med 348 23 (2003) 2339-2347
3. Miki Y., Swensen J., Shattuck-Eidens D., et al. A strong candidate for the breast cancer and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71
4. Wooster R., Bignell G., Lancaster J., et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378 (1995) 789-792
5. Chen S., and Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25 11 (2007) 1329-1333
6. Antoniou A., Pharoah P.D.P., Narod S., et al. Average risk of breast cancer and ovarian cancer associated with BRCA1 and BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72 (2003) 1117-1130
7. Venkitaraman A.R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cellule 108 (2002) 171-182
8. Loescher L.J., and Whitesell L. The biology of cancer. In: Tranin A.S., Masny A., and Jenkins J. (Eds). Genetics in oncology practice: cancer risk assessment (2003), Oncology Nursing Society, Pittsburgh (PA) 23-56
9. Fries M.H., Holt C., Carpenter I., et al. Guidelines for evaluation of patients at risk for inherited breast and ovarian cancer: recommendations of the Department of Defense Familial Breast/Ovarian Cancer Research Project. Mil Med 167 2 (2002) 93-98
10. National Comprehensive Cancer Network Inc. The NCCN Clinical Practice Guidelines in Oncology™ Genetic/familial high-risk assessment: breast and ovarian: clinical practice guidelines in oncology. National Comprehensive Cancer Network. To view the most recent and complete version of the NCCN Guidelines, go online to Available at:. www.nccn.org Accessed March 11, 2009
11. Hamilton R.J., Williams J.K., Bowers B.J., et al. Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer. J Genet Couns 18 2 (2008) 147-154
12. Kenen R., Ardern-Jones A., and Eles R. Family stories and the use of heuristics: women from suspected hereditary breast and ovarian (HBOC) families. Sociol Health Illn 25 7 (2003) 838-865
13. Skirton H., and Eiser C. Discovering and addressing the client's lay construct of genetic disease: an important aspect of genetic health care?. Res Theory Nurs Pract 17 4 (2003) 339-352
14. Blanchard D., Erblich J., Montgomery G.H., et al. Read all about it: the over-representation of breast cancer in popular magazines. Prev Med 35 (2002) 343-348
15. Dillard A.J., McCaul K.D., and Klein W.M.P. Resisting good news: reactions to breast cancer risk information. Health Commun 19 (2006) 115-123
16. Katapodi M.C., Lee K.A., Facione N.C., et al. Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 38 (2004) 388-402
17. Lloyd S., Watson M., Waites B., et al. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending genetic counseling. Br J Cancer 74 3 (1996) 482-487
18. Press N., Fishman J.R., and Koenig B.A. Collective fear, individualized risk: the social and cultural context of genetic testing for breast cancer. Nurs Ethics 7 3 (2000) 237-249
19. Kauff N.D., Satagopan J.M., Robson M.E., et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346 21 (2002) 1609-1615
20. Rebbeck T.R., Lynch H.T., Neuhausen S., et al. Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 346 21 (2002) 1616-1622
21. Friebel T.M., Domchek S.M., Neuhausen S.L., et al. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 carriers. Clin Breast Cancer 7 11 (2007) 875-882
22. Oei A., Massuger L., Bulten J., et al. Surveillance of women at high risk for hereditary ovarian cancer is inefficient. Br J Cancer 94 (2006) 814-819
23. Hamilton R.J., and Bowers B.J. The theory of genetic vulnerability: a Roy model exemplar. Nurs Sci Q 20 3 (2007) 254-265
24. Tessaro I., Borstelmann N., Regan K., et al. Genetic testing for susceptibility to breast cancer: findings from women's focus groups. J Womens Health 6 3 (1997) 317-327
25. Kenen R., Ardern-Jones A., and Eeles R. Living with chronic risk: healthy women with a family history of breast/ovarian cancer. Health Risk Soc 5 3 (2003) 315-331
26. Hallowell N., Foster C., Eles R., et al. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer. Soc Sci Med 59 (2004) 553-565
27. Petrucelli N., Daly M.B., Culver J.O., et al. BRCA1 and BRCA2 Hereditary breast/ovarian cancer. June 19, 2007. Available at:. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=brca1 Accessed March 12, 2009
28. Kenen R., Ardern-Jones A., and Eeles R. "Social separation" among women under 40 years of age diagnosed with breast cancer and carrying a BRCA1 or BRCA2 mutation. J Genet Couns 15 3 (2006) 149-162
29. Patenaude A. Parent child communication about hereditary disease risks. ELSI transactions from cancer to genomic medicine. Cleveland, Ohio, 2008.
30. Tercyak K.P., Hughes C., Snyder C., et al. Parental communication of BRCA1/2 genetic test results to children. Patient Educ Couns 42 3 (2001) 213-224
31. Forrest K., Simpson S.A., Wilson B.J., et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 64 (2003) 317-326
32. Hamilton R.J., Bowers B.J., and Williams J.K. Disclosing genetic test results to family members. J Nurs Scholarsh 37 1 (2005) 18-24
33. van Oostrom I., Meijers-Heijboer E.J., Lodder L.N., et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 21 20 (2003) 3867-3874
34. Claes E., Evers-Kiebooms G., Denayer L., et al. Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure. J Genet Couns 14 5 (2005) 349-363
35. Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 14 (2005) 1060-1074
36. Mellon S., Gold R., Janisse J., et al. Risk perception and cancer worries in families at increased risk for familial breast/ovarian cancer. Psychooncology 17 (2008) 756-766
37. Smith A.W., Dougall A.L., Posluszny D.A., et al. Psychological distress and quality of life associated with genetic testing for breast cancer risk. Psychooncology 17 (2008) 767-773
38. Dorval M., Bouchard K., Maunsell E., et al. Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control population. J Genet Couns 17 4 (2008) 314-326
39. d'Agincourt-Canning L. A gift or a yoke? Women's and men's responses to genetic risk information from BRCA1 and BRCA2 testing. Clin Genet 70 (2006) 462-472
40. Hamilton RJ, Williams JK, Bowers B, et al. Living with genetic test results for hereditary breast and ovarian cancer. J Nurs Scholarsh, accepted for publication.
41. Jenkins J., and Masny A. Why should oncology nurses be interested in genetics?. In: Tranin A.S., Masny A., and Jenkins J. (Eds). Genetics in oncology practice (2003), Oncology Nursing Society, Pittsburgh (PA) 1-12
42. Douglas H., Hamilton R.J., and Grubs R.E. The effect of BRCA gene testing on family relationships: a thematic analysis of qualitative interviews. J Genet Couns (2009) pre-pub online
43. Collins F. Shattuck lecture-medical and societal consequences of the human genome project. N Engl J Med 341 1 (1999) 28-37
44. Clarke S., Butler K., and Esplen M. The phases of disclosing BRCA1/2 genetic information to offspring. Psychooncology 17 8 (2008) 797-803
45. Hallowell N., Foster C., Eeles R., et al. Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. J Med Ethics 29 2 (2003) 74-91
46. Hallowell N., Ardern-Jones A., Eeles R., et al. Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their families. Sociol Health Illn 28 7 (2006) 969-988
47. d'Agincourt-Canning L. Genetic testing for hereditary breast and ovarian cancer: responsibility and choice. Qual Health Res 16 6 (2006) 97-118
48. King M.-C., Marks J.H., and Mandell J.B. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302 24 (2003) 643-646
49. USPTF. Screening for breast cancer, topic page. Available at:. http://www.ahrq.gov/clinic/uspstf/uspsbrca.htm Accessed March 10, 2009
50. Van Dijk S., Van Asperen C.J., Jacobi C.E., et al. Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message. Genet Test 8 3 (2004) 235-239
51. Nathanson K.L., Wooster R., and Weber B. Breast cancer genetics: what we know and what we need to know. Nat Med 7 5 (2001) 552-556
52. O'Neill S.C., Rini C., Goldsmith R.E., et al. Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes. Psychooncology (2009) Online prepub
53. Lerman C., Hughes C., Croyle R.T., et al. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med 31 (2000) 75-80
54. Michie S., Smith J.A., Senior V., et al. Understanding why negative genetic test results sometimes fail to reassure. Am J Med Genet 119 (2003) 340-347
55. Kriege M., Brekelmans C.T.M., Boetes C., et al. Efficacy of MRI and mammography for breast cancer screening in women with familial or genetic predisposition. N Engl J Med 351 5 (2004) 427-437
56. Hallowell N., Mackay J., Richards M., et al. High-risk premenopausal women's experiences of undergoing oophorectomy: a descriptive study. Genet Test 8 2 (2004) 148-156
57. Friedman L.C., and Kramer R.M. Reproductive issues for women with BRCA mutations. J Natl Cancer Inst Monogr 34 (2005) 83-86
58. Fry A., Busby-Earle C., Rush R., et al. Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer. Psychooncology 10 (2001) 231-241
59. Meiser B., Tiller K., Gleeson M.A., et al. Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer. Psychooncology 9 (2000) 496-503
60. Wilson B.J., Forrest K., van Teijlingen E.R., et al. Family communication about genetic risk: the little that is known. Community Genet 7 (2004) 15-24
61. Geirdal A.O., Reichelt J.G., Dahl A.A., et al. Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations. Fam Cancer 4 (2005) 121-126
62. Keller M., Jost R., Haunstetter C.M., et al. Comprehensive genetic counseling for families at risk for HNPCC: impact on distress and perceptions. Genet Test 6 4 (2002) 291-302
63. Mesters I., Ausems M., Eichhorn S., et al. Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study. Fam Cancer 4 (2005) 163-167
64. van Oostrom I., Meijers-Heijboer H., Duivenvoorden H.J., et al. A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships. Psychooncology 16 4 (2007) 320-328
65. Peterson S.K., Watts B.G., Koehly L.M., et al. How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C Semin Med Genet 119C (2003) 78-86
66. Collins F.S. The Human Genome Project and the future of medicine. Ann N Y Acad Sci 882 (1999) 42-55